GNRH1 and acute kidney injury: The observed increased risk of acute kidney injury with the GnRH antagonist degarelix is difficult to interpret as it was one of a number of analyses, based upon relatively few acute kidney injury events and because degarelix users are likely to have more advanced prostate cancer.